Awardee OrganizationSCRIPPS RESEARCH INSTITUTE, THE
Description
Abstract Text
Project summary
Maintenance of homeostasis at barrier tissues is essential for mammalian health. At these sites, the concerted
communication of different cell lineages is central for integrating a wide range of signals, to promote responses
against noxious stimuli while preventing exacerbated responses against benign stimuli. The skin represents an
organ where neuro-immune interactions may be of major biological significance, as it is one of the largest
interfaces between the body and the environment, integrating signals including temperature, mechanical
stimulus, tissue damage, and pathogenic and commensal microbes. Both the nervous and immune systems are
involved in sensing potentially damaging perturbations and mounting appropriate responses for the avoidance
and clearance of noxious stimuli. Recently, we successfully identified the existence of a cellular neuro-immune
circuit formed by the interaction of sensory neurons and regulatory T cells (Treg cells). This neuro-immune circuit
between Treg cells and sensory nerves is mediated at least partially through Treg cell production of enkephalins,
endogenous opioids that induce analgesia. Through enkephalin production Treg cells dampen nociceptor
activation to prevent exacerbated skin inflammation. We additionally find that other non-neuronal skin resident
populations can produce enkephalins. The work proposed in this application seeks to uncover how endogenous
opioid signaling mediates communication between sensory neurons and immune cells to regulate immune
homeostasis in the skin. Understanding the roles for distinct sources of endogenous opioids may lead to the
therapeutic harnessing of these for the treatment of chronic conditions, and may provide alternatives to the use
of exogenous opioids. In addition, this project will, at a global scale, dissect the heterogeneity of responses in
neuronal populations innervating the skin to different pathological contexts, and how these responses relate to
their interactions with immune cells. This project will provide new insights on the molecular underpinnings of
endogenous analgesics’ role in tissue homeostasis, as well as further our understanding on how sensory
neurons respond to different types of inflammation, two key concepts that may have major implications on novel
therapies for chronic conditions involving pain, itch and inflammation.
Public Health Relevance Statement
Project Narrative
Bidirectional crosstalk between sensory neurons and immune cells is central for integrating a wide range of
signals, promoting responses against noxious stimuli while preventing exacerbated responses against benign
stimuli. Dysregulation of this balance can lead to maladaptive responses culminating in chronic conditions
involving inflammation, pain and itch. This study seeks to probe neuro-immune interactions that promote tissue
homeostasis, which may result in novel therapies for chronic conditions involving pain, itch and inflammation.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
781613492
UEI
PHZJFZ32NKH4
Project Start Date
04-September-2024
Project End Date
31-August-2027
Budget Start Date
04-September-2024
Budget End Date
31-August-2027
Project Funding Information for 2024
Total Funding
$1,656,000
Direct Costs
$900,000
Indirect Costs
$756,000
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$1,656,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1DP2AR085223-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1DP2AR085223-01
Patents
No Patents information available for 1DP2AR085223-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1DP2AR085223-01
Clinical Studies
No Clinical Studies information available for 1DP2AR085223-01
News and More
Related News Releases
No news release information available for 1DP2AR085223-01
History
No Historical information available for 1DP2AR085223-01
Similar Projects
No Similar Projects information available for 1DP2AR085223-01